Circulating Integrin Alpha4/Beta7+ Lymphocytes Targeted by Vedolizumab have a Pro-Inflammatory Phenotype

2017 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    1
    Citations
    NaN
    KQI
    []